
    
      Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence
      and severity of sleep apnea syndrome in patients treated for cancer of the upper
      aerodigestive tract.

      Patients are included in the study when they are hospitalized for panendoscopy. Thereafter,
      it takes about 1 month to start any treatment. The duration of treatment is estimated at
      about 5 months (the longest regimen would be induction chemotherapy followed by surgery and
      adjuvant complementary treatment). After which the patient follows a usual course of care
      including, at the end of the treatment of his cancer of the upper aerodigestive tract,
      screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and
      ventilatory polygraphy).
    
  